Sodium Thiosulfate
Cognitive/Functional Effects
OHSU Knight Cancer InstituteSmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Cognitive/Functional Effects cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Irinotecan Alliance for Clinical Trials in Oncology | Phase 3 | BB |
(+)-VINCRISTINE Radiation Therapy Oncology Group | Phase 3 | BB |
Namenda Radiation Therapy Oncology Group | Phase 3 | BB |
METHOTREXATE OHSU Knight Cancer Institute | Phase 2 | BB |
Sra-333 Alliance for Clinical Trials in Oncology | Phase 3 | BB |
View all 22 →
Same molecule, other indications
Sodium Thiosulfate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →